Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 140

1.

ACP Journal Club. Adding rifaximin to lactulose increased reversal and decreased mortality in hepatic encephalopathy.

Kowdley KV, Burman BE.

Ann Intern Med. 2013 Oct 15;159(8):JC8. doi: 10.7326/0003-4819-159-8-201310150-02008. No abstract available.

PMID:
24126669
2.

Rifaximin for episodic, overt hepatic encephalopathy: the data are catching up to clinical practice, but questions remain.

Congly SE, Leise MD.

Am J Gastroenterol. 2014 Apr;109(4):598. doi: 10.1038/ajg.2013.480. No abstract available.

PMID:
24698864
3.

The cost-effectiveness and budget impact of competing therapies in hepatic encephalopathy - a decision analysis.

Huang E, Esrailian E, Spiegel BM.

Aliment Pharmacol Ther. 2007 Oct 15;26(8):1147-61.

4.

A randomized, double-blind, controlled trial comparing rifaximin plus lactulose with lactulose alone in treatment of overt hepatic encephalopathy.

Sharma BC, Sharma P, Lunia MK, Srivastava S, Goyal R, Sarin SK.

Am J Gastroenterol. 2013 Sep;108(9):1458-63. doi: 10.1038/ajg.2013.219. Epub 2013 Jul 23.

PMID:
23877348
5.

Response to Congly and Leise.

Praveen S, Chander SB.

Am J Gastroenterol. 2014 Apr;109(4):598-9. doi: 10.1038/ajg.2013.482. No abstract available.

PMID:
24698865
6.
7.

[Intestine specific broad spectrum antibiotic. Rifaximin: therapy option in hepatic encephalopathy].

[No authors listed]

MMW Fortschr Med. 2014 Feb 20;156(3):64-5. German. No abstract available.

PMID:
24938070
8.

Analysis of hospitalizations comparing rifaximin versus lactulose in the management of hepatic encephalopathy.

Neff GW, Kemmer N, Zacharias VC, Kaiser T, Duncan C, McHenry R, Jonas M, Novick D, Williamson C, Hess K, Thomas M, Buell J.

Transplant Proc. 2006 Dec;38(10):3552-5.

PMID:
17175328
9.
10.

Rifaximin treatment in hepatic encephalopathy.

Sharma P, Sharma BC.

N Engl J Med. 2010 Jun 24;362(25):2423-4; author reply 2424-5. No abstract available.

PMID:
20578274
11.

Durability of rifaximin response in hepatic encephalopathy.

Neff GW, Jones M, Broda T, Jonas M, Ravi R, Novick D, Kaiser TE, Kemmer N.

J Clin Gastroenterol. 2012 Feb;46(2):168-71. doi: 10.1097/MCG.0b013e318231faae.

PMID:
22011586
12.

Rifaximin for the treatment of hepatic encephalopathy.

Mantry PS, Munsaf S.

Transplant Proc. 2010 Dec;42(10):4543-7. doi: 10.1016/j.transproceed.2010.09.173.

PMID:
21168733
13.

Lactulose, rifaximin or branched chain amino acids for hepatic encephalopathy: what is the evidence?

Gluud LL, Dam G, Borre M, Les I, Cordoba J, Marchesini G, Aagaard NK, Vilstrup H.

Metab Brain Dis. 2013 Jun;28(2):221-5. doi: 10.1007/s11011-012-9372-0. Epub 2012 Dec 29. Review.

PMID:
23275147
14.

Optimal treatment of hepatic encephalopathy.

Waghray A, Waghray N, Kanna S, Mullen K.

Minerva Gastroenterol Dietol. 2014 Mar;60(1):55-70. Review.

PMID:
24632768
15.

Rifaximin treatment in hepatic encephalopathy.

Bass NM, Mullen KD, Sanyal A, Poordad F, Neff G, Leevy CB, Sigal S, Sheikh MY, Beavers K, Frederick T, Teperman L, Hillebrand D, Huang S, Merchant K, Shaw A, Bortey E, Forbes WP.

N Engl J Med. 2010 Mar 25;362(12):1071-81. doi: 10.1056/NEJMoa0907893.

16.

Should We Treat Minimal/Covert Hepatic Encephalopathy, and with What?

Henderson PK, Herrera JL.

Clin Liver Dis. 2015 Aug;19(3):487-95. doi: 10.1016/j.cld.2015.04.002. Epub 2015 May 19. Review.

PMID:
26195203
17.

Improving treatments for hepatic encephalopathy.

[No authors listed]

Gastroenterol Nurs. 2012 Jul-Aug;35(4):291-2. doi: 10.1097/SGA.0b013e31825ad583. No abstract available.

PMID:
22847290
18.

Rifaximin therapy in minimal hepatic encephalopathy cirrhotics.

Zullo A, Hassan C, Lorenzetti R.

Am J Gastroenterol. 2011 Nov;106(11):2041; author reply 2041-2. doi: 10.1038/ajg.2011.216. No abstract available.

PMID:
22056578
19.

Can we ignore minimal hepatic encephalopathy any longer?

Qadri AM, Ogunwale BO, Mullen KD.

Hepatology. 2007 Mar;45(3):547-8. No abstract available.

PMID:
17326151
20.

Gut flora and hepatic encephalopathy in patients with cirrhosis.

Riordan SM, Williams R.

N Engl J Med. 2010 Mar 25;362(12):1140-2. doi: 10.1056/NEJMe1000850. No abstract available.

PMID:
20335591

Supplemental Content

Support Center